A patient treated two weeks ago with Augmentin (amoxicillin‑clavulanate) and neomycin/polymyxin B/hydrocortisone ear drops for otitis media with possible tympanic membrane perforation for seven days now has bloody ear drainage; what are the appropriate next steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Otoscopic Examination and Switch to Fluoroquinolone Ear Drops

The patient requires urgent otoscopic examination to assess tympanic membrane status, and if perforation is confirmed or suspected, immediate discontinuation of neomycin-containing drops with transition to fluoroquinolone ear drops (ofloxacin or ciprofloxacin-dexamethasone) for 7-10 days. 1

Critical First Steps

1. Stop Neomycin/Polymyxin/Hydrocortisone Immediately

The bloody drainage two weeks after treatment completion raises two critical concerns:

  • Persistent or recurrent infection through the perforated tympanic membrane
  • Potential ototoxicity from aminoglycoside exposure (neomycin) through the perforation

Neomycin-containing drops are contraindicated with tympanic membrane perforation due to documented ototoxicity risk 2, 3, 4. While clinical ototoxicity is rare, the risk increases with prolonged or repeated exposure through middle ear access 3, 5.

2. Perform Otoscopic Examination

Assess for:

  • Tympanic membrane perforation status (persistent vs healed)
  • Granulation tissue (suggests chronic infection or malignant otitis externa)
  • Middle ear effusion or purulence
  • External auditory canal inflammation (distinguishes otitis externa from otitis media with perforation)
  • Foreign body or cholesteatoma (alternative diagnoses)

Management Algorithm Based on Findings

If Tympanic Membrane Perforation Confirmed:

Initiate fluoroquinolone ear drops (ofloxacin or ciprofloxacin-dexamethasone) twice daily for 7-10 days 1. These are the only topical antibiotics approved for middle ear use and demonstrate:

  • 77-96% clinical cure rates vs 30-67% with oral antibiotics 1
  • Superior bacterial eradication, particularly for Pseudomonas aeruginosa and Staphylococcus aureus (common pathogens in chronic drainage) 1
  • No ototoxicity risk unlike aminoglycosides 1, 4, 6

Application technique:

  • Patient lies with affected ear up
  • Fill ear canal completely with drops
  • Remain in position 3-5 minutes
  • "Pump" tragus several times to facilitate middle ear penetration 1, 7

Avoid oral antibiotics unless patient appears systemically ill, as topical therapy is significantly more effective 1.

If Bloody Drainage Without Clear Perforation:

Consider:

  • Granulation tissue from chronic inflammation - may require ENT referral for debridement
  • Acute otitis externa superimposed on healed perforation
  • Contact dermatitis from neomycin (13-30% prevalence with chronic use) 8

Still initiate fluoroquinolone drops as first-line given recent perforation history and superior safety profile.

Red Flags Requiring ENT Referral

Refer to otolaryngology if:

  • Drainage persists >7 days on appropriate fluoroquinolone therapy 1
  • Granulation tissue present (rule out cholesteatoma, malignancy) 8
  • Hearing loss develops or worsens 1
  • Severe otalgia, fever, or systemic symptoms (concern for mastoiditis, intracranial extension) 9, 10
  • Diabetes or immunocompromised (risk of necrotizing otitis externa) 9

Critical Pitfalls to Avoid

  1. Do not restart neomycin/polymyxin drops - aminoglycosides are ototoxic with middle ear exposure 2, 3, 4

  2. Do not prescribe oral antibiotics alone - topical fluoroquinolones achieve 77-96% cure vs 30-67% with oral therapy 1

  3. Do not use "wait and see" - bloody drainage suggests active infection requiring treatment, not observation

  4. Do not assume healed perforation - 2 weeks post-treatment is insufficient time to confirm healing; many perforations remain patent

  5. Avoid water exposure until drainage resolves - use cotton with petroleum jelly during bathing 1

Duration and Follow-up

  • Treat for 7-10 days with fluoroquinolone drops 1
  • Reassess at 7 days - if drainage persists, refer to ENT 1
  • Audiometry if hearing concerns or prolonged symptoms 1
  • Recheck at 6-12 months after resolution to confirm perforation healing and absence of middle ear effusion 1

The evidence strongly supports that bloody drainage in this context represents either persistent infection through an unhealed perforation or recurrent infection, both requiring fluoroquinolone ear drops as definitive therapy 1. The previous neomycin-containing regimen was inappropriate if perforation was present and must not be repeated 2, 3.

References

Guideline

clinical practice guideline: tympanostomy tubes in children.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013

Research

Ototoxicity of ear drops: a clinical perspective.

The American journal of otology, 1995

Research

Safety of topical ear drops containing ototoxic antibiotics.

The Journal of otolaryngology, 1997

Guideline

clinical practice guideline: acute otitis externa executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Guideline

clinical practice guideline: acute otitis externa.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Guideline

acr appropriateness criteria® inflammatory ear disease.

Journal of the American College of Radiology, 2025

Guideline

panel 7: otitis media: treatment and complications.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.